title: [Resection of Paraaortic Lymph Node Recurrence Wherein Complete Response to Bevacizumab Was Observed after Surgery for Sigmoid Colon Cancer].
abstract: We report a case of resection of a paraaortic lymph node recurrence, wherein complete response to bevacizumab was observed. Our patient was a 50-year-old woman who had a paraaortic lymph node recurrence during adjuvant chemotherapy with FOLFOX 6 months after surgery for sigmoid colon cancer. She was treated with chemotherapy consisting of FOLFOX plus bevacizumab/FOLFIRI plus bevacizumab, which suppressed progression of the periaortic lymph node recurrence. She underwent surgery for the paraaortic lymph node recurrence, and the pathologic result was complete response. We report that bevacizumab was effective for her paraaortic lymph node recurrence.
authors.affiliation: Dept. of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation, Toshima Hospital.
authors.forename: Hideaki
authors.initials: H
authors.lastname: Ganno
authors.forename: Machiko
authors.initials: M
authors.lastname: Kawaguchi
authors.forename: Yuya
authors.initials: Y
authors.lastname: Umebayashi
authors.forename: Syouta
authors.initials: S
authors.lastname: Aoyama
authors.forename: Hirofumi
authors.initials: H
authors.lastname: Sugita
authors.forename: Takeharu
authors.initials: T
authors.lastname: Noguchi
authors.forename: Hidetoshi
authors.initials: H
authors.lastname: Amagasa
authors.forename: Kenichiro
authors.initials: K
authors.lastname: Imai
authors.forename: Katsunori
authors.initials: K
authors.lastname: Ami
authors.forename: Akira
authors.initials: A
authors.lastname: Fukuda
authors.forename: Nobuhiko
authors.initials: N
authors.lastname: Aoki
authors.forename: Masayuki
authors.initials: M
authors.lastname: Ando
authors.forename: Shikofumi
authors.initials: S
authors.lastname: Tei
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001011:Aorta / Q000473:pathology / Q000601:surgery; D000068258:Bevacizumab / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008197:Lymph Node Excision; D008198:Lymph Nodes; D008207:Lymphatic Metastasis; D008875:Middle Aged; D012811:Sigmoid Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
chemical_list: D000068258:Bevacizumab